# Genotype Based Personalized Prescription of Nevirapine

> **NCT00986063** · PHASE4 · COMPLETED · sponsor: **Surakameth Mahasirimongkol** · enrollment: 1200 (actual)

## Conditions studied

- Nevirapine Induced Rash
- Nevirapine Induced Hepatitis
- HIV
- Adverse Side Effects
- AIDS
- HIV Infections

## Interventions

- **GENETIC:** Genetic test for NVP induced rash
- **OTHER:** 3TC/D4T/NVP or 3TC/AZT/NVP

## Key facts

- **NCT ID:** NCT00986063
- **Lead sponsor:** Surakameth Mahasirimongkol
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2012-07
- **Final completion:** 2012-12
- **Target enrollment:** 1200 (ACTUAL)
- **Last updated:** 2013-04-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00986063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00986063, "Genotype Based Personalized Prescription of Nevirapine". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00986063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*